Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. - Wikidata - wikimedia - TriplyDB

Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.

Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.

http://www.wikidata.org/entity/Q37920834

about

Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma.The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer.Expansion of melanoma-specific T cells from lymph nodes of patients in stage III: implications for adoptive immunotherapy in treating cancer.Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.Protein and non-protein biomarkers in melanoma: a critical update.Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review.Penile tumours: a review.Discordance in histopathologic evaluation of melanoma sentinel lymph node biopsy with clinical follow-up: results from a prospectively collected database.Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.Missing sentinel lymph node in cutaneous melanoma.Sentinel lymph node biopsy for melanoma in pregnant women.Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma.MSLT-I-response of clinical trial investigators.Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma.Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts.Clinicopathologic Factors Predictive of Occult Lymph Node Involvement in Cutaneous Head and Neck Melanoma.A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma.Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.Psychosocial consequences of skin cancer screening.Molecular pathology of cutaneous melanoma Melanoma

P2860

Q24187945-61A6E092-7E42-455C-A2FF-6BE0EB648A64 Q24201860-87705AA5-487C-439D-BCF5-BCA7AA5EBA3E Q26996059-74DC4E5A-DD02-45A3-AB2B-53951C8B2AA8 Q27851927-88AD1BF4-60C4-40DD-9566-BBEA2CAA3DC9 Q28077949-52CA8AF0-70FF-4CA0-8215-77075121BCFB Q34640145-96D4B4AC-52FD-4A52-B45F-5C57F473820D Q35646297-0F6A8101-F07A-4D4C-95D6-73CE0D58CA66 Q36060302-37C0F15B-3A45-45ED-B16F-463898C7038A Q36098663-E0C362AF-CE57-47D1-A4E1-86845A3772D7 Q36291295-A5F3B6D6-FD0F-4630-A280-2C0D4FA7B1FC Q36321208-775EE203-4777-4B7D-9E08-1B7077D084AC Q37375980-F0C9EACE-31A2-44AF-AB76-B818DCC9E911 Q37400708-31B08DD3-F83D-4EBF-A5C2-5046FF3430B5 Q37631156-23ECE767-395C-404B-869D-9099FFD754C2 Q38050990-EA619921-85B1-4E12-A3F8-7BADEEBC9818 Q38187594-B7F1399C-5EC9-4629-AA72-092BB6E344DD Q38200655-A6D7D661-3883-4D1A-9201-8D0723256AD6 Q38213235-DB3A281D-7C53-4EBF-8857-3C004F5C2D78 Q38849622-F227A7D1-9563-482B-AFB6-4E7D324D360C Q38854848-4B4C4412-144F-4021-B1F8-98A4873B1E87 Q39119920-E5AE89DE-0383-4E00-AC27-997A397A369F Q40958894-28F57F48-03D4-4FD0-8451-DBA7372D916A Q41639791-94592B56-E4CC-4EC8-B38E-02AC9FD05370 Q42175933-5146DF14-77B0-47B9-82FF-69AB27255CEC Q44332123-97E53002-E2C2-4235-9162-5B82326A3C7D Q45121629-C7F9EB5E-EE98-459C-B150-0A867BC6BF5B Q46125629-F09FF68A-9342-4296-A459-C4D3AAFC196D Q46411728-6D48121C-99DF-4CF6-84AF-AF119CE4515B Q46580935-AA093E86-D431-4C32-9CF9-1E954CF45E71 Q49379553-B0271BF0-BFDB-4814-A33F-5B458B4F8CE8 Q50122047-2855F3E0-21D5-44F1-B86E-DCD3ED38866C Q50545431-3755D5BA-8A5E-4846-97F4-B07073BDB4E5 Q50583302-7364BFFA-0F61-490A-A5F7-7B3EEE54AADF Q50611404-54328C81-E426-4043-8377-D4B5AC807FA6 Q55040465-262B654E-8927-430A-BAEC-1F8A0130FC1C Q56428911-D49C2ACC-CE0B-478A-936E-BA106B4B7300 Q57571786-202D7052-488D-4247-B6C7-0193DBB10EB2

P2860

Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.

http://www.wikidata.org/entity/Q37920834

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@en

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@nl

type

label

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@en

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@nl

prefLabel

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@en

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@nl

P1433

Q37920834-A30B06B5-DD59-4968-AC21-711B7D820731

P1476

Q37920834-230CD059-4DFC-487E-B261-DADF677F1600

P2093

Q37920834-3FF22284-8015-4F04-8373-7AE96BFE7ACC

Q37920834-627087DB-C5CE-4B6F-A48A-4E84844E5015

Q37920834-63D50D84-208E-49D8-BDA7-F5B3B2B21DC9

Q37920834-9C0B4210-09E4-49A1-A33E-463C2CC3CBFD

P2860

Q37920834-0E95FB74-7B73-4329-A3A4-11AF4D55C2C5

Q37920834-0ECDD010-59FA-4504-9FCC-A71440D54B4E

Q37920834-1624352F-6DAE-44DE-84A0-549236A3E527

Q37920834-3A2B9D60-F3D6-45D1-B28A-A492009BF3C5

Q37920834-47F9C3D6-7D61-4BBE-83AA-D66D17F6C948

Q37920834-4E8619E5-D6A8-4B25-ACD1-62220F327114

Q37920834-622C40B2-1078-47B6-8ECC-4B9474DA7365

Q37920834-73891998-99A4-4154-BC7B-0F47D681D977

Q37920834-79A816C8-49AE-47C2-A2AB-99D4675ED4B3

Q37920834-8D2578A3-9A95-433E-AC13-ABFBF6DB8239

P304

Q37920834-EB3CDBBD-1E67-4893-8B3D-58E4E3F714F8

P31

Q37920834-7AAD36A2-DDF7-4DCD-B400-CDA5C48005D8

P356

Q37920834-759297F4-266D-418A-8669-54536732A133

P433

Q37920834-50F7A5F3-C8C6-4765-A6A7-5C22D823927D

P478

Q37920834-5558A5E3-DF30-403C-A575-D0EFE86B780C

P577

Q37920834-02C49341-D917-4D38-8D92-118F37877E75

P698

Q37920834-A698B400-0949-4C87-AEC4-DA61DCB34301

P356

P1433

Journal of Surgical Oncology

P1476

Update on the melanoma staging ...... nd primary tumor mitotic rate.

@en

P2093

Charles M Balch

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Gershenwald

http://www.w3.org/2001/XMLSchema#string

John F Thompson

http://www.w3.org/2001/XMLSchema#string

Seng-Jaw Soong

http://www.w3.org/2001/XMLSchema#string

P2860

Final version of 2009 AJCC melanoma staging and classification

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

Predictors of occult nodal metastasis in patients with thin melanoma.

Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma.

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Sentinel-node biopsy or nodal observation in melanoma.

Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

P304

379-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.21876

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21858832

http://www.w3.org/2001/XMLSchema#string